Skip to main content
. Author manuscript; available in PMC: 2016 May 18.
Published in final edited form as: Biochem Pharmacol. 2015 Dec 21;102:130–140. doi: 10.1016/j.bcp.2015.12.010

Table 1.

Overview of changes in gene expression in RAW264.7 cells upon C646 (at 30 μM) or SAHA (at 0.41 μM) pre-treatment, as well as in PCLS upon C646 (at 25 μM) or SAHA (at 0.41 μM) pre-treatment followed by an inflammatory LPS and IFNγ stimulus. The percentage of change compared to vehicle treatment is indicated. Upreguation is indicated by ↑, downregulation by ↓, and no effect by –. N.E. = gene is not expressed, and N.D. = gene expression was not determined.

C646 TNFα iNOS IL-1β IL-6 IL-8 IL-12b
RAW264.7 ↓ (54.1 %) - - - N.E. ↓ (54.2 %)
PCLS ↓ (79.1 %) ↓ (58.4 %) ↓ (72.3 %) - - ↓ (85.0 %)
SAHA TNFα iNOS IL-1β IL-6 IL-8 IL-12b
RAW264.7 - - ↑ (317 %) N.D. N.E. -
PCLS - ↓ (39.9 %) ↑ (41.5 %) ↑ (58.8 %) N.D. -